Advantage Alpha Capital Partners LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Advantage Alpha Capital Partners LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2020$4,339,000
-45.5%
36,536
-60.0%
0.95%
-48.4%
Q3 2020$7,961,000
-11.3%
91,246
-8.9%
1.84%
-12.4%
Q2 2020$8,971,000
+248.7%
100,170
+288.0%
2.10%
+129.0%
Q1 2020$2,573,00025,8180.92%
Other shareholders
HAEMONETICS CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders